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Abstract 
 
Accumulating evidences indicate an importance of NK cells in controlling tumor 
growth and metastasis. NK cell subsets display diversities in their function and 
tissue distribution and Mac-1hi CD27lo NK cells are the predominant population 
of lung-resident NK cells. Although lung is a major organ where primary tumor 
develops and cancer cells metastasizes, there is no clear evidence whether 
circulating NK cells and/or tissue-resident NK cells control tumor growth in lung. 
In this study, we examined an anti-tumor function of lung-resident NK cells to 
control pulmonary tumor growth. In an orthotopic lung tumor model, NK cells 
controlled the pulmonary tumor growth, and mature circulating NK cell subsets 
were increased in tumor-bearing lungs through CXCR3-dependent mechanism. 
Although such increase of migratory NK cell subsets can be blocked by 
anti-CXCR3 treatment, there was no difference in the pulmonary tumor growth in 
anti-CXCR3-treated mice compared with control mice. In addition to pulmonary 
tumor growth, lung-resident NK cells, but not migratory NK cells, play a dominant 
role for controlling metastatic growth of cancer cells in lung. These results 
strongly indicate an importance of lung-resident NK cells for controlling 
pulmonary tumor growth.  
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Introduction 
 
NK cells can be dissected into functionally distinct subsets by the expression of 
Mac-1 and CD27 (1-4). Along with phenotypically immature Mac-1lo CD27hi NK 
cell subset (Mac-1lo), we showed that CD27 expression further dissects the 
mature Mac-1hi NK cell population into CD27hi and CD27lo subsets  (1, 2). Such 
NK cell subset shows distinct tissue distribution as well as their functional 
diversity. Interestingly, the CD27lo subset is comparatively excluded from BM 
and LN, and is the dominant in blood circulation or in peripheral tissues (1, 2). In 
addition, NK cells are rapidly recruited to tissues at the site of immune 
responses including tumor, and the chemokine receptor CXCR3 has been 
known to play an important role in NK cell recruitment to tumor 
microenvironment (5-8). Amongst NK cell sub-populations, Mac-1lo and CD27hi 
NK cell subsets constitutively express CXCR3, therefore those NK cell subsets 
are dominantly recruited into tumor (1, 6, 7).  
 Pulmonary NK cells play an important role in pathology of respiratory 
diseases, including infectious diseases, allergy and cancer (9-11). Accumulating 
evidences suggest that lung tissue-specific NK cells can be functionally and 
phenotypically distinct from other NK cells (1, 12). Under steady-state conditions, 
NK cells account for about 10% of total lymphocyte population in the lung, and 
those lung-resident NK cells are mostly CD27lo subset. The CD27lo NK cell 
subset express highly mature phenotype bearing with self-recognizing inhibitory 
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receptors and being tightly regulated in their responsiveness (1, 13). Although 
the importance of NK cells in tumor surveillance has been widely appreciated, a 
contribution of such tissue-resident NK cells is not understood. While lung is a 
major organ where primary tumors develop and cancer cells metastasize, it is 
not clear the role of lung tissue-resident NK cells for tumor control. In this study, 
we examined the role of lung resident NK cells in controlling primary lung tumor 
growth by using an orthotopic lung tumor model. We demonstrated that the 
lung-resident NK cells, but not migratory NK cells, play a dominant role in 
controlling pulmonary primary and metastatic tumor growth.  
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Materials and Methods 
 
Mice 
Wild-type C57BL/6 (B6) mice were purchased from CLEA Japan, Inc. (Tokyo, 
Japan). IFN-γ –/– (IFN-γ -/-) mice on B6 background were kindly provided by Dr. Y. 
Iwakura (Tokyo University of Science, Chiba, Japan) and maintained at 
Laboratory Animal Research Center, Institute of Medical Science, The University 
of Tokyo. In some experiments, groups of mice were treated with either 
anti-asialo-GM1 antibody (150 µg/mouse, Wako Chemicals, Osaka, Japan) on 
Day -3 and -1, anti-CXCR3 mAb (500 µg/mouse, clone CXCR3-173, Bio X Cell, 
NH, USA) on Day -1, 0, 2, 4 and 6, or FTY720 (1 mg/kg, Sigma, MI, USA) daily 
from Day 0 to 9 (where day 0 is the day of primary tumor inoculation). All 
experiments were approved and performed according to the guidelines of the 
Animal Care and Use Committee of the Graduate School of Pharmaceutical 
Sciences of The University of Tokyo, the Care and Use of Laboratory Animals of 
University of Toyama and the Animal Care and Use Committee of Institute of 
Medical Science of the University of Tokyo. 
 
Cells and reagents 
The mouse Lewis Lung carcinoma cell line (3LL) was kindly provided by Dr. 
Kazuyoshi Takeda (Juntendo University), and the luciferase-expressing 3LL cell 
line (3LL-Luc2) was prepared as previously described (14). pGL4.50 
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[luc2/CMV/Hygro] vector, and D-luciferin were obtained from Promega (WI, 
USA). Lipofectamine 2000 was purchased from Invitrogen (Carlsbad, CA). 
Hygromycin B was obtained from Nacalai Tesque (Kyoto, Japan). 
 
Intra-pulmonary tumor cell implantation and bioluminescent imaging 
3LL-Luc2 cells were suspended (5 x 105 cells/ml) in PBS containing 500 µg/ml of 
Matrigel (BD Bioscience). Intra-pulmonary implantation procedure was 
described before (14). Briefly, B6 mice were anesthetized with isoflurane and 
were made a small skin incision at left chest wall. On observing the motion of left 
lung, 20 µl of cell suspension were directly injected into the lung with a 29-gauge 
needle attached with 0.3ml of syringe (Beckton & Dickinson). The skin incision 
was closed with a surgical skin clip. To obtain bioluminescent images, mice were 
injected with D-luciferin (Promega, 150 mg/kg i.p.) and luminescence was 
measured with an in vivo imaging system (IVIS Lumina II, Perkin Elmer, MA, 
USA) 10 minutes after the D-luciferin injection.  
 
Flow cytometry 
3LL-Luc2 cells were cells (104) were inoculated intra-pulmonary. Ten days after 
the inoculation, lung tissues were dissected, minced and digested with 2 mg/mL 
collagenase (Roche Diagnostics GmbH, Mannheim, Germany) and 0.1 mg/mL 
DNase I (Roche Diagnostics GmbH) in serum-free RPMI 1640 for 1 hr at 37 ºC. 
Samples were further homogenized through wire mesh. For flow cytometry 
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analysis, cells were first pre-incubated with anti-CD16/32 (2.4G2) mAb to avoid 
non-specific binding of antibodies to FcγR. The cells were then incubated with a 
saturating amount of fluorophore-conjugated mAb. Antibodies against CD3e 
(2C11), NK1.1 (PK136), CD11b (M1/70), CD27 (LG.3A10) were purchased from 
Biolegend (San Diego, CA, USA), eBioscience (San Diego, CA, USA) or Tombo 
Bioscience (San Diego, CA, USA). Flow cytometry analysis was performed with 
a FACS Canto (BD Bioscience, San Jose, CA, USA) and the data were analyzed 
with FlowJo software (Tree Star, Ashland, OR, USA). 
 
Statistical analysis 
All data were obtained from a group of 6 to 9 mice and are representative of at 
least two independent experiments. Data were analyzed for statistical 
significance using the Student’s t-test. P values less than 0.05 were 
considered significant. 
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Results 
 
Characterization of NK cells in pulmonary tumor 
 
To understand the role of NK cells in controlling lung cancer, we first analyzed 
NK cells in primary lung tumors by implanting orthotopicaly murine 3LL-Luc2 
cells(n=9). Either tumor-bearing or control lung lobes were harvested 10 days 
after the tumor inoculation and the NK cell population were analyzed by flow 
cytometry. While there was no significant difference in the total NK cell 
population, the subsets of NK cells showed a significant difference between 
control and tumor-bearing lungs (Fig. 1). The subsets of mouse NK cells can be 
determined by the expression of two markers Mac-1 (CD11b) and CD27, and the 
functional and phenotypic differences in those NK cell subsets are well 
characterized (1). In tumor-bearing lungs, the population of migratory Mac-1lo 
and CD27hi NK cell subsets were significantly increased whereas no obvious 
change was observed in tissue-resident CD27lo NK cell subset (Fig. 1). There 
was no difference in CD3+ T cell population between control and tumor-bearing 
lungs (data not shown). 
Next, we examined whether NK cells can be recruited from circulation 
into the tumor-bearing lung by CXCR3- or S1P-dependent mechanism, that are 
known as important for in vivo NK cell trafficking (1, 5, 6, 15, 16). As shown in 
Figure 2A, the population of migratory Mac-1lo and CD27hi NK cell subsets in the 
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tumor-bearing lungs were significantly decreased in mice treated with 
anti-CXCR3 (aCXCR3: n=9). Contrary, there was no such difference in NK cell 
subsets of tumor-bearing lungs in FTY720-treated mice (n=7). Considering a 
significant reduction of CD3+ T cells in the FTY720 treated tumor-bearing lungs 
was observed (data not shown), the trafficking of Mac-1lo and CD27hi NK cells to 
primary lung tumor should be dependent on CXCR3, but not S1P, as similar to 
that to subcutaneous tumor (6, 7).  
 
Lung-resident NK cells control pulmonary tumor growth and metastasis  
 
To determine the importance of NK cells for controlling primary lung tumor, we 
examined the growth of 3LL-Luc2 tumors in lung of NK cell-depleted mice (NK 
dep: n=9) treated with anti-asialo-GM1 antibody. In NK cell-depleted mice, the 
lung tumor growth was significantly enhanced compared with control B6 mice 
(Fig. 3A and B), indicating NK cells significantly contribute to anti-tumor 
immunity in controlling pulmonary tumor growth. Such NK cell-dependent 
anti-tumor immune response against primary lung tumor required IFN-γ because 
there was no difference in the presence or absence of NK cells for controlling 
primary lung tumor growth in IFN-γ-deficient mice (Fig. 3C: n=8). These results 
clearly indicate that NK cells control lung primary tumor growth in 
IFN-γ-dependent mechanism. 
We next examined the contribution of migratory Mac-1lo and CD27hi NK 
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cells and/or tissue-resident CD27lo NK cells in controlling primary lung tumor. 
The trafficking of Mac-1lo and CD27hi NK cells to primary lung tumor was blocked 
by treating mice with anti-CXCR3 (Figure 2A). As shown in Figure 3D, there was 
no differences in the growth of lung tumor between control and 
anti-CXCR3-treated mice. There was also no difference in the growth of lung 
tumor with or without FTY720 treatment (Fig. 3E). Collectively, these results 
indicate the importance of lung-resident NK cells, rather than NK cells recruited 
from circulation, in controlling pulmonary tumor growth.  
The importance of NK cells for protecting lung metastasis has been 
widely recognized, and we previously reported that IFN-γ production by lung NK 
cells is critical for such metastasis protection (11). As shown in Figure 4, NK cell 
depletion significantly enhanced the metastatic growth of 3LL-Luc2 cells in lung, 
whereas anti-CXCR3 treatment did not show any difference to control mice in 
lung metastasis of 3LL-Luc2 cells. Along with our presented finding in controlling 
pulmonary tumor growth, lung-resident NK cells, but not NK cells recruited by 
CXCR3, play an important role in controlling metastatic growth of 3LL-Luc2 cells. 
These results further emphasize the general importance of lung-resident NK 
cells for pulmonary immune-surveillance of cancer.  
  
 
	 11	
Discussion 
 
It has been widely recognized an importance of NK cells in controlling tumor 
growth and metastasis (17-19). Although NK cell has been known to play a 
critical role in the resistance to lung metastases (11), it is not clear whether 
circulating NK cells and/or tissue resident NK cells control tumor growth in lung. 
While mature CD27hi and CD27lo NK cells reside in both lymphoid and 
non-lymphoid organs, CD27lo subset is a predominant NK cell population within 
lung (1, 2). In this study, we examined the role of lung resident NK cells in 
controlling primary lung tumor growth. In an orthotopic lung tumor model, NK 
cells controlled the pulmonary tumor growth, and mature circulating NK cell 
subsets, both Mac-1lo and CD27hi subsets, were increased in tumor-bearing 
lungs through CXCR3-dependent mechanism. Although such increase of 
migratory NK cell subsets can be blocked by anti-CXCR3 treatment, there was 
no difference in the pulmonary tumor growth in anti-CXCR3-treated mice 
compared with control mice. In addition to pulmonary tumor growth, 
lung-resident NK cells, but not migratory NK cells, play a dominant role in 
controlling lung metastatic growth. These results strongly indicate an importance 
of lung-resident NK cells for controlling pulmonary tumor growth.   
 NK cells account for about 10% of circulating lymphocytes, and also be 
found in the peripheral tissues including spleen, liver, gut, lung lymph node and 
uterus (1, 9, 20). The presence of NK cells in those peripheral organs has been 
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believed as a result of chemokine- and sphingosine 1-phosphate 
(S1P)-dependent distribution from the circulation (15, 16, 21-23). In lung tissue, 
NK cells play an important role in several pulmonary diseases other than cancer, 
including influenza infection, asthma, tuberculosis and others (24). It has been 
suggested that pulmonary NK cells are also recruited from the periphery (12, 25), 
however, the importance of lung-resident NK cells in those pathologies are not 
yet clear. We previously reported that the importance of liver-resident NK cells in 
controlling metastasis of cancer through TRAIL-dependent mechanism, and 
such NK cell surveillance in liver metastases was dependent on unique NK cell 
subset reside in liver (26, 27). In addition, we also reported that IFN-γ production 
by lung NK cells is critical for metastasis protection of murine melanoma cells 
(11). Further study is required for understanding whether lung-resident NK cells 
display any functional distinction to NK cells in other organs. 
While NK cell trafficking under homeostatic condition are not clearly 
defined yet, the rapid accumulation of NK cells in the tumor microenvironment 
has been known to be controlled by CXCR3 (5)	(6, 8). In contrast to the findings 
of subcutaneous tumors	(6)	(7), CXCR3 did not show any significant role in 
controlling tumor growth in lung. Moreover, the blocking of S1P pathway by 
treating with FTY720 did not affect NK cell-dependent tumor control in lung 
though S1P5-dependent NK cell trafficking was shown to be resistant to FTY720 
(15), suggesting NK cell recruitment through either CXCR3 or S1P pathway are 
not involved in pulmonary tumor control. It has been reported that the 
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maintenance of lung NK cells is dependent on IL-15	(28)	(29). In mice, 
lung-resident NK cells are mostly CD27lo NK cells subset which shows 
hypo-responsiveness to those homeostatic cytokines for NK cell including IL-15 
(1)	(3). The mature CD27lo NK cell subset expresses higher levels of inhibitory 
Ly-49 and CD94/NKG2 complexes (13), therefore lung-resident NK cells 
assumed to be tightly regulated for their responsiveness. Nevertheless, further 
study will be required to fully understand NK cell behavior in the lung tissue 
microenvironment for maximizing their anti-tumor function against lung cancer 
and developing new NK cell-targeted immunotherapy. 
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Figure legends 
 
Figure 1. Characterization of NK cells in pulmonary 3LL-Luc2 tumor. 
B6 mice were inoculated intra-pulmonary with 3LL-Luc2 (104) and lungs were 
harvested 10 days after the inoculation. Mononuclear cells were isolated from 
control lung (Control) or tumor-bearing lung (Tumor) and then subjected to flow 
cytometry analysis. The representative FACS plots from the indicated groups of 
mice are shown and numbers represent percentage of cells in the different gates. 
The proportion of NK cells (A, NK1.1+CD3- cells) or NK cell subsets (Mac-1lo : 
Mac-1lo CD27hi, CD27hi : Mac-1hi CD27hi, CD27lo : Mac-1hi CD27lo, electronically 
gated on NK1.1+CD3- cells) from the indicated lung samples are presented. The 
data represent mean ± SEM and representative of two experiments. *P < 0.05 
compared with control group. 
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Figure 2. CXCR3 controls migratory NK cell accumulation in pulmonary 
3LL-Luc2 tumor.  
3LL-Luc2 (104) were inoculated intra-pulmonary to B6 mice. (A) To block 
CXCR3, mice were treated with anti-CXCR3 (500 µg/mouse, i.p.) on day -1, 0, 2, 
4 and 6. (B) FTY720 (1 mg/kg, i.p.) were treated daily from day 0 to 9 (day 0 = 
tumor inoculation). Mononuclear cells were isolated from tumor-bearing lung and 
then subjected to flow cytometry analysis. The proportion of NK cell subsets 
(Mac-1lo : Mac-1lo CD27hi, CD27hi : Mac-1hi CD27hi, CD27lo : Mac-1hi CD27lo, 
electronically gated on NK1.1+CD3- cells) from the indicated lung samples are 
presented. The data represent mean ± SEM and representative of two 
experiments. *P < 0.05 compared with control group. 
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Figure 3. Lung-resident NK cells control pulmonary 3LL-Luc2 tumor 
growth. 
3LL-Luc2 (104) were inoculated intra-pulmonary to B6 WT mice or IFNγ -/- mice. 
To deplete NK cells (NK dep), mice were treated with anti-asGM1 antibody (150 
µg/mouse, i.p.) on day -3 and -1 (day 0 = tumor inoculation). To block CXCR3, 
mice were treated with anti-CXCR3 (500 µg/mouse, i.p.) on day -1, 0, 2, 4 and 6. 
FTY720 (1 mg/kg, i.p.) were treated daily from day 0 to 9 (day 0 = tumor 
inoculation). The representative bioluminescent images of mice bearing 
orthotopic 3LL-Luc2 tumor are shown (A). The bioluminescence of 3LL-Luc2 
tumor was monitored in WT mice (B, D, E) or IFNγ -/- mice (B). Luminescence 
was normalized by that of the individual mouse on day 0. Data are presented as 
the mean ± SEM. *P < 0.05 compared with control group. 
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Figure 4. Lung-resident NK cells control pulmonary 3LL-Luc2 tumor 
metastases. 
3LL-Luc2 (104) were inoculated intravenously to B6 mice. To deplete NK cells 
(NK dep), mice were treated with anti-asGM1 antibody (200 µg/mouse, i.p.) on 
day -3 and -1 (day 0 = tumor inoculation). To block CXCR3, mice were treated 
with anti-CXCR3 (500 µg/mouse, i.p.) on day -1, 0 and 2. The bioluminescence 
of lungs were measured at 4 days after the tumor inoculation. The 
representative bioluminescent images of lung inoculated (A) and summary of 
lung metastases (B) are shown. Data are presented as the mean ± SEM. *P < 
0.05 compared with control group. 
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